Reporte zur Charge UT7731

Symptomtext

fluzone qiv np being administered to a geriatric patient accidentally instead of fluzone high-dose quadrivalent, with no reported adverse event; Initial information received on 21-Oct-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves an unknown age geriatric female patient who was accidentally administered influenza quadrival A-B vaccine [fluzone QIV] instead of fluzone high-dose quadrivalent, with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 20-Oct-2022, the geriatric patient accidentally received a dose of suspect influenza quadrival A-B vaccine (lot UT7731, formulation, strength, dose, route and administration site: unknown) for influenza instead of fluzone high-dose quadrivalent, with no reported adverse event (wrong product administered). It was reported "The patient is requesting to know if she should be revaccinated. Caller is on her way to work and will call back when at work with safety report information". It was unknown if there were lab data/results available. Action taken: Not applicable. Outcome: Unknown. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.